Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
14
5
2021
pubmed:
15
5
2021
medline:
1
9
2021
Statut:
ppublish
Résumé
The use of genomics within cancer research and clinical oncology practice has become commonplace. Efforts such as The Cancer Genome Atlas have characterized the cancer genome and suggested a wealth of targets for implementing precision medicine strategies for patients with cancer. The data produced from research studies and clinical care have many potential secondary uses beyond their originally intended purpose. Effective storage, query, retrieval, and visualization of these data are essential to create an infrastructure to enable new discoveries in cancer research. Moffitt Cancer Center implemented a molecular data warehouse to complement the extensive enterprise clinical data warehouse (Health and Research Informatics). Seven different sequencing experiment types were included in the warehouse, with data from institutional research studies and clinical sequencing. The implementation of the molecular warehouse involved the close collaboration of many teams with different expertise and a use case-focused approach. Cornerstones of project success included project planning, open communication, institutional buy-in, piloting the implementation, implementing custom solutions to address specific problems, data quality improvement, and data governance, unique aspects of which are featured here. We describe our experience in selecting, configuring, and loading molecular data into the molecular data warehouse. Specifically, we developed solutions for heterogeneous genomic sequencing cohorts (many different platforms) and integration with our existing clinical data warehouse. The implementation was ultimately successful despite challenges encountered, many of which can be generalized to other research cancer centers.
Identifiants
pubmed: 33989014
doi: 10.1200/CCI.20.00175
pmc: PMC8240785
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
561-569Subventions
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Références
Genome Med. 2015 Jul 29;7(1):80
pubmed: 26221189
Nat Rev Clin Oncol. 2014 Jul;11(7):432-8
pubmed: 24687035
JCO Clin Cancer Inform. 2018 Dec;2:1-8
pubmed: 30652543
Cancer J. 2011 Nov-Dec;17(6):528-36
pubmed: 22157297
Int J Mol Sci. 2017 Feb 15;18(2):
pubmed: 28212287
EGEMS (Wash DC). 2018 Jun 01;6(1):13
pubmed: 30094285
PLoS One. 2017 Apr 7;12(4):e0172187
pubmed: 28388645
BMC Bioinformatics. 2015 Dec 29;16:415
pubmed: 26714792
Oncologist. 2017 Feb;22(2):144-151
pubmed: 28179575
Cancer Inform. 2017 Mar 02;16:1176935117694349
pubmed: 28469389
J Am Med Inform Assoc. 2010 Mar-Apr;17(2):124-30
pubmed: 20190053
J Am Med Inform Assoc. 2015 Nov;22(6):1173-8
pubmed: 26198304
AMIA Annu Symp Proc. 2007 Oct 11;:548-52
pubmed: 18693896
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Database (Oxford). 2020 Jan 1;2020:
pubmed: 32293013
J Biomed Inform. 2014 Dec;52:28-35
pubmed: 24534443
Arch Pathol Lab Med. 2016 Sep;140(9):958-75
pubmed: 26901284
J Clin Oncol. 2013 May 20;31(15):1806-14
pubmed: 23589557
Gene Ther. 2017 Sep;24(9):551-561
pubmed: 28805797
AMIA Annu Symp Proc. 2006;:1040
pubmed: 17238659
Yearb Med Inform. 2013;8:178-84
pubmed: 23974569
Cancer Inform. 2007 Jun 08;3:255-74
pubmed: 19455246
Appl Transl Genom. 2015 Sep 14;6:18-25
pubmed: 27054074
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
BMC Cancer. 2006 May 05;6:120
pubmed: 16677389
J Pers Med. 2017 Aug 22;7(3):
pubmed: 28829408
Nature. 2011 Feb 10;470(7333):204-13
pubmed: 21307933
J Clin Bioinforma. 2015 Mar 26;5:4
pubmed: 25834725